Raloxifene, which was originally developed to prevent and treat osteoporosis, was later found to help reduce the risk of invasive breast cancer in high-risk women. Now it also may help reduce the risk of breast cancer in other women.
Show Someone You Care
MyDocHub
Latest Posts
- My Take on The All New Atkins Advantage Diet
- Get Your Pet A Checkup
- Global Economic Pinch Affecting Cosmetic Surgery
- University of Central Florida Professor Creates Two Compounds For Destroying Breast Cancer Tumors
- British Patients To Review Doctors on Government Health Site
- Cancer Risk Not Reduced By Antioxidants Supplements
- Happy New Year From MyDocHub.com
- End of Big Pharma Gifts For Doctors
- Extra Sleep and Reduced Heart Risk
- Trius Therapeutics Named in Business Week’s Most Successful U.S. Startups 2008
Recent Comments
- Weight Loss » Blog Archive » My Take on The All New Atkins Advantage Diet on post My Take on The All New Atkins Advantage Diet
- My Take on The All New Atkins Advantage Diet at MyDocHub Blog - Online Health Community on post Moderated, Reasonable Balanced Diet is Key to Losing Weight
- Lana Russo on post IV Push and Diana Levine
- Lisa Gualtieri on post Eggs and Heart Disease
- Extra Sleep and Reduced Heart Risk at MyDocHub Blog - Online Health Community on post 5 Ways To Get More Sleep
- Trius Therapeutics Named in Business Week’s Most Successful U.S. Startups 2008 at MyDocHub Blog - Online Health Community on post Clostridium Difficile - Also known as C. diff
- MePregnant on post Fetus in Fetu Video
- Basic Principles of Complementary and Alternative Medicine (CAM … on post Basic Principles of Complementary and Alternative Medicine (CAM)
- SIDS Sleeping Discussion With My Sister-in-Law at MyDocHub Blog - Online Health Community on post Sudden Infant Death Syndrome and Infant Position
- Website Directory - Birth Defect Prevention on post Pre-Term Babies Have Twice the Risk of Birth Defects
2 Responses to “Raloxifene (Evista) Helps Reduce Breast Cancer Risk”